2016
DOI: 10.1016/j.envpol.2015.12.017
|View full text |Cite
|
Sign up to set email alerts
|

Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
25
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(26 citation statements)
references
References 55 publications
(58 reference statements)
1
25
0
Order By: Relevance
“…Acting unselectively on DNA, it has been hypothesized that anticancer drugs may harm all eukaryotic organisms by cytotoxic, genotoxic, mutagenic and carcinogenic effects (Johnson et al, 2008;Vyas et al, 2014). The biological risk posed by these anticancer molecules and their metabolites in aquatic species is not well elucidated (Mater et al, 2014), with few data on acute and chronic ecotoxicological assessments in algae Tetrahymena pyriformis (Bonnet et al, 2003), Pseudomonas putida (Zounková et al, 2007) and Pseudokirchneriella subcapitata (Zounková et al, 2007;Brezovsek et al, 2014;Česen et al, 2016); polychaete Nereis diversicolor (Fonseca et al, 2017); bivalve mollusc Mytilus galloprovincialis (Trombini et al, 2016); cladocera crustaceans Daphnia pulex (DellaGreca et al, 2007;Borgatta et al, 2015Borgatta et al, , 2016, D. magna (Zounková et al, 2007;Parrella et al, 2014aParrella et al, , 2014bParrella et al, , 2015 and Ceriodaphnia dubia (DellaGreca et al, 2007;Parrella et al, 2014aParrella et al, , 2014bParrella et al, , 2015; crustacean amphipod Ampelisca brevicornis (Moreira et al, 2016); and the fishes Danio rerio (Kovacs et al, 2015), Pimephales promelas (Winter et al, 2007) and Oryzias latipes (Sun et al, 2011). Limited information exists regarding Environmental risk assessment (ERA) for anticancer drugs.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Acting unselectively on DNA, it has been hypothesized that anticancer drugs may harm all eukaryotic organisms by cytotoxic, genotoxic, mutagenic and carcinogenic effects (Johnson et al, 2008;Vyas et al, 2014). The biological risk posed by these anticancer molecules and their metabolites in aquatic species is not well elucidated (Mater et al, 2014), with few data on acute and chronic ecotoxicological assessments in algae Tetrahymena pyriformis (Bonnet et al, 2003), Pseudomonas putida (Zounková et al, 2007) and Pseudokirchneriella subcapitata (Zounková et al, 2007;Brezovsek et al, 2014;Česen et al, 2016); polychaete Nereis diversicolor (Fonseca et al, 2017); bivalve mollusc Mytilus galloprovincialis (Trombini et al, 2016); cladocera crustaceans Daphnia pulex (DellaGreca et al, 2007;Borgatta et al, 2015Borgatta et al, , 2016, D. magna (Zounková et al, 2007;Parrella et al, 2014aParrella et al, , 2014bParrella et al, , 2015 and Ceriodaphnia dubia (DellaGreca et al, 2007;Parrella et al, 2014aParrella et al, , 2014bParrella et al, , 2015; crustacean amphipod Ampelisca brevicornis (Moreira et al, 2016); and the fishes Danio rerio (Kovacs et al, 2015), Pimephales promelas (Winter et al, 2007) and Oryzias latipes (Sun et al, 2011). Limited information exists regarding Environmental risk assessment (ERA) for anticancer drugs.…”
Section: Introductionmentioning
confidence: 99%
“…The levels of CP detected in hospital effluents, WWTPs influents and effluents, surface waters and sediments are indicated in Table 1. Data suggests that this drug and its metabolites are likely to contribute to overall toxicity in receiving waters (Kiffmeyer et al, 1998;Yasunaga et al, 2006;Kosjek and Heath, 2011;Česen et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…At chronic exposure, 5-fluorouracil produced in zebrafish histopathological changes, and genotoxic effects at environmental concentrations (Kovacs et al, 2015). It is crucial, therefore, to consider the possible toxic/genotoxic effects in organisms exposed over their life span to the continuous presence and possible accumulation of not just the parent anticancer drugs, but also their metabolites and transformation products (Toolaram et al, 2014;Cesen et al, 2016b). Hospital wastewaters are a major source of anticancer drugs.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, CP metabolism is probably different in bacteria cells in comparison to human cells. Maybe, as a result of CP biochemical changes, other intermediate metabolites are formed, which can also generate free radical production [47][48][49][50]57].…”
Section: Antimicrobial Activity Studymentioning
confidence: 99%